Tissue Total RNA, Breast, left
CAT#: CR562606
RNA (5 µg); Breast, left; Carcinoma in situ of breast, ductal
Special Offer: Get a 25% discount on this product. Use code: “Tissue25".
USD 318.00
3 Days*
Size
Product Images
Frequently bought together (3)
48 samples covering 5-normal, 11-Stage I, 8-IIA, 6-IIB, 8-IIIA, 2-IIIB, 4-IIIC, 4-IV. Available in 2, 5, 10 identical plates.
New! ER, PR and HER2 in Clinical Info.
New! ER, PR and HER2 in Clinical Info.
USD 850.00
Specifications
Product Data | |
Disease State | Cancer |
Diagnosis Category | Breast Cancer |
Tissue | Breast |
Frozen Sample ID | FR000430E7 |
Case ID | CI0000019681 |
Prep | 2 |
Vial ID | RN00002E92 |
Tissue of Origin | Breast, left |
Site of Finding | Breast, left |
Appearance | Tumor |
Sample Diagnosis (from Pathology Verification) | Carcinoma in situ of breast, ductal |
Normal | 10% |
Lesional | 0% |
Tumor | 70% |
Tumor Hypo/Acellular Stroma | 0% |
Tumor Hypercellular Stroma | 20% |
Necrosis | 0% |
Bioanalyzer Ratio (28S/18S) | 1.89 |
CASE Diagnosis (from medical center path report) | Adenocarcinoma of breast, ductal |
Age | 46 |
Gender | Female |
Tumor Grade | Nottingham G2: 6-7 points Intermediate combined grade (moderately favorable) |
Minimum Stage Grouping | I |
T (Extent of Primary Tumor) | T1b |
N (Lymph node metastasis) | NX |
M (Distant metastasis) | MX |
Diagnostic Test Results | Progesterone receptor ~ PR ! by IHC,Positive; Estrogen receptor ~ ER ! by IHC,Positive; ERBB2,Not amplified; HER2 ~ ERBB2 ~ Neu ! by IHC,Positive, weak; MSA ~ Muscle Specific Actin,Negative; p63 ~ p53 homolog ! by IHC,Positive |
Documents
SDS |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.